Page last updated: 2024-09-05

dabigatran and Liver Steatosis

dabigatran has been researched along with Liver Steatosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abrahams, SR; Divanovic, S; Flick, MJ; Goss, A; Kopec, AK; Luyendyk, JP; Mackman, N; Mullins, ES; Owens, AP; Palumbo, JS; Thornton, S; van Ryn, J; Weiler, H	1
Flick, MJ; Joshi, N; Kassel, KM; Kopec, AK; Luyendyk, JP; Sullivan, BP; Towery, KL	1

Other Studies

2 other study(ies) available for dabigatran and Liver Steatosis

Article	Year
Thrombin promotes diet-induced obesity through fibrin-driven inflammation. The Journal of clinical investigation, 2017, Aug-01, Volume: 127, Issue:8 Topics: Adipose Tissue; Adiposity; Amino Acid Motifs; Animals; Blood Glucose; Body Composition; Body Weight; Coagulants; Dabigatran; Diet, High-Fat; Fatty Liver; Female; Fibrin; Genotype; Homozygote; Inflammation; Liver; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Obesity; Thrombin; Weight Gain	2017
Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice. The Journal of pharmacology and experimental therapeutics, 2014, Volume: 351, Issue:2 Topics: Alanine Transaminase; Animals; Benzimidazoles; beta-Alanine; Bile Acids and Salts; Dabigatran; Diet, High-Fat; Fatty Liver; Fibrin; Gene Expression; Inflammation; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Thrombin; Weight Gain	2014

Article

Year

Thrombin promotes diet-induced obesity through fibrin-driven inflammation.

The Journal of clinical investigation, 2017, Aug-01, Volume: 127, Issue:8

Topics: Adipose Tissue; Adiposity; Amino Acid Motifs; Animals; Blood Glucose; Body Composition; Body Weight; Coagulants; Dabigatran; Diet, High-Fat; Fatty Liver; Female; Fibrin; Genotype; Homozygote; Inflammation; Liver; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Obesity; Thrombin; Weight Gain

2017

Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice.

The Journal of pharmacology and experimental therapeutics, 2014, Volume: 351, Issue:2

Topics: Alanine Transaminase; Animals; Benzimidazoles; beta-Alanine; Bile Acids and Salts; Dabigatran; Diet, High-Fat; Fatty Liver; Fibrin; Gene Expression; Inflammation; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Thrombin; Weight Gain

2014